SK biopharmaceuticals

SK biopharmaceuticals

Developing innovative and next-generation drugs for central nervous system.

HQ location
Seongnam-si, South Korea
Website
Launch date
Market cap
$6.0b
Enterprise value
$5.9b
Share price
KRW92500.00 326030.KS
  • Edit

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
KRW202120222023202420252026
Revenues000000000000000000000000
% growth-(41 %)44 %54 %28 %29 %
EBITDA000000000000000000000000
% EBITDA margin21 %(46 %)(3 %)20 %--
Profit000000000000000000000000
% profit margin15 %(57 %)(9 %)44 %--
EV000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget000000000000000000000000
R&D % of revenue27 %50 %39 %29 %--

Source: Company filings or news article, Equity research estimates

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by SK biopharmaceuticals

Edit
Proteovant Therapeutics
ACQUISITION by SK biopharmaceuticals Jun 2023